L. Yang, J. He, Wen Dong, Xin Zhang, C. Zhou, X. Ren, Weiqun Yan
{"title":"Protective effect of recombinant bovine pancreatic trypsin inhibitor on chronic liver injury induced by carbon tetrachloride in rats","authors":"L. Yang, J. He, Wen Dong, Xin Zhang, C. Zhou, X. Ren, Weiqun Yan","doi":"10.3867/J.ISSN.1000-3002.2008.03.007","DOIUrl":null,"url":null,"abstract":"AIM To observe the protection of recombinant bovine pancreatic trypsin inhibitor(rBPTI) against chronic liver injury.METHODS Ninety eight rats were randomized into 7 groups:normal control,model control,rBPTI 20,40 and 80 MU·kg-1,aprotinin 80 MU·kg-1 and hepatocyte growth-promoting factor(pHGF) 100 mg·kg-1 groups.The chronic liver injury rat model was induced by carbon tetrachloride(CCl4).After 8 weeks,the rats were administered(ip) with rBPTI,aprotinin or pHGF daily for 4 weeks except that in normal and model control groups.The glutamic-pyruvic transaminase(GPT) and glutamic-oxalacetic transaminase(GOT) activities,albumin(Alb) content,Alb and globulin content ratio(A/G),sialic acid(SA) content in serum were measured.Hydroxyproline(Hyp) level and histopathological changes of hepatic tissue were also examined.RESULTS Compared with normal control group,the activities of serum GPT and GOT,and the contents of SA in serum and Hyp in liver tissue in model group were increased,and the content of serum Alb and A/G ratio were decreased.Compared with model group,rBPTI(20,40 and 80 MU·kg-1) decreased the activities of GPT and GOT,and the contents of SA in serum and Hyp in liver tissue.The content of serum Alb and A/G ratio were increased by rBPTI.In addition,rBPTI alleviated chronic hepatic injuries such as fatty degeneration and liver fibrosis significantly.CONCLUSION rBPTI has protective and anti-fibrosis effects against chronic liver injury induced by CCl4,and the efficiency is equivalent as aprotinin in the observed dosages.","PeriodicalId":10149,"journal":{"name":"中国药理学与毒理学杂志","volume":"22 1","pages":"193-198"},"PeriodicalIF":0.0000,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国药理学与毒理学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3867/J.ISSN.1000-3002.2008.03.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
AIM To observe the protection of recombinant bovine pancreatic trypsin inhibitor(rBPTI) against chronic liver injury.METHODS Ninety eight rats were randomized into 7 groups:normal control,model control,rBPTI 20,40 and 80 MU·kg-1,aprotinin 80 MU·kg-1 and hepatocyte growth-promoting factor(pHGF) 100 mg·kg-1 groups.The chronic liver injury rat model was induced by carbon tetrachloride(CCl4).After 8 weeks,the rats were administered(ip) with rBPTI,aprotinin or pHGF daily for 4 weeks except that in normal and model control groups.The glutamic-pyruvic transaminase(GPT) and glutamic-oxalacetic transaminase(GOT) activities,albumin(Alb) content,Alb and globulin content ratio(A/G),sialic acid(SA) content in serum were measured.Hydroxyproline(Hyp) level and histopathological changes of hepatic tissue were also examined.RESULTS Compared with normal control group,the activities of serum GPT and GOT,and the contents of SA in serum and Hyp in liver tissue in model group were increased,and the content of serum Alb and A/G ratio were decreased.Compared with model group,rBPTI(20,40 and 80 MU·kg-1) decreased the activities of GPT and GOT,and the contents of SA in serum and Hyp in liver tissue.The content of serum Alb and A/G ratio were increased by rBPTI.In addition,rBPTI alleviated chronic hepatic injuries such as fatty degeneration and liver fibrosis significantly.CONCLUSION rBPTI has protective and anti-fibrosis effects against chronic liver injury induced by CCl4,and the efficiency is equivalent as aprotinin in the observed dosages.
中国药理学与毒理学杂志Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
0.20
自引率
0.00%
发文量
6787
期刊介绍:
Chinese Journal of Pharmacology and Toxicology was first published in November 1986. As a journal of high academic value jointly edited by the Chinese Pharmacological Society, Chinese Society of Toxicology and the Academy of Military Medical Sciences (AMMS), it is a dominating one in China’s biomedicine, devoted to publication of research findings, reviews of special topic and new technologies and methods in every branch of experimental toxicology and pharmacology.